Neuroimaging and therapeutics in movement disorders (Q30989947)

5 November 2017

1 reference

title

Neuroimaging and therapeutics in movement disorders (English)

1 reference

5 November 2017

0 references

1 reference

David Eidelberg

1 reference

5 November 2017

Thomas Eckert

1 reference

5 November 2017

1 April 2005

1 reference

5 November 2017

1 reference

5 November 2017

1 reference

5 November 2017

1 reference

5 November 2017

361-371

1 reference

Single-photon emission computed tomography in neurotherapeutics

5 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Foundations of advanced magnetic resonance imaging

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

The role of radiotracer imaging in Parkinson disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Levodopa and the progression of Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Deep brain stimulation for the treatment of Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

The subthalamic nucleus in the context of movement disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Dystonia genotypes, phenotypes, and classification

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Imaging end points for monitoring neuroprotection in Parkinson's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Functional brain networks in DYT1 dystonia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

The metabolic anatomy of tremor in Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Dopamine transporter imaging with fluorine-18-FPCIT and PET.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Opposite motor effects of pallidal stimulation in Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Metabolic correlates of pallidal neuronal activity in Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Multiple system atrophy: a review of 203 pathologically proven cases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease

28 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

28 July 2018

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

The metabolic topography of normal aging

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

A clinicopathologic study of 100 cases of Parkinson's disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Multi-center study of Parkinson mortality with early versus later dopa treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Prevalence and natural history of progressive supranuclear palsy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Positron emission tomography and single-photon emission computed tomography in central nervous system drug development.

28 July 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Metabolic changes following subthalamotomy for advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Evolving metabolic changes during the first postoperative year after subthalamotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Stem cells for cell therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Primary dystonia: is abnormal functional brain architecture linked to genotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

The metabolic anatomy of Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Executive processes in Parkinson's disease: FDG-PET and network analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Metabolic correlates of levodopa response in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy—parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Cerebral metabolic changes in early multiple system atrophy: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Onset and rate of striatal atrophy in preclinical Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Genetics of primary dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Impaired sequence learning in carriers of the DYT1 dystonia mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Regional metabolism in primary torsion dystonia: effects of penetrance and genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Effects of levodopa infusion on motor activation responses in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Functional correlates of pallidal stimulation for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Functional imaging in Parkinson's disease: activation studies with PET, fMRI and SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Relationship between muscle output and functional MRI-measured brain activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Enhancement of brain activation during trial-and-error sequence learning in early PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Pallidal stimulation for parkinsonism: improved brain activation during sequence learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Effects of levodopa on motor sequence learning in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Learning networks in health and Parkinson's disease: reproducibility and treatment effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1602%2FNEURORX.2.2.361

Brain networks and clinical penetrance: lessons from hyperkinetic movement disorders

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

SPECT imaging in Parkinson's disease.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

Reproducibility of regional metabolic covariance patterns: comparison of four populations.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

123Iβ-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1064997

The metabolic topography of parkinsonism

25 November 2018

1 reference

12 December 2020

Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET

1 reference

12 December 2020

Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease

1 reference

12 December 2020

Frequency-dependent changes of regional cerebral blood flow during finger movements

1 reference

12 December 2020

The metabolic topography of idiopathic torsion dystonia

1 reference

12 December 2020

Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy

1 reference

12 December 2020

1 reference

12 December 2020

Differentiation of atypical parkinsonian syndromes with routine MRI

1 reference

12 December 2020

Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis

1 reference

12 December 2020

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Microstructural white matter changes in carriers of the DYT1 gene mutation

1 reference

12 December 2020

1 reference

12 December 2020

Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography

1 reference

12 December 2020

Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration

1 reference

12 December 2020

[Atypical Parkinson syndrome]

1 reference

12 December 2020

What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study

1 reference

12 December 2020

Identifiers

DOI

10.1602/NEURORX.2.2.361

1 reference

5 November 2017

1 reference

PMC publication ID

1064997

5 November 2017

PubMed publication ID

15897956

1 reference

PMC publication ID

1064997